rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AVXL
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      AVXL Deadline: AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Nov 11MorningstarAVXL
      What's Next for Anavex Life Sciences Corp. Shareholders After 6.35% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
      Nov 9MorningstarAVXL
      Anavex Deadline: AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Nov 5MorningstarAVXL
      What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
      Nov 5MorningstarAVXL
      Anavex Appoints Terrie Kellmeyer as President and CEO

      Tipranks Press Release.

      Nov 4The Globe and MailAVXL
      Anavex appoints Terrie Kellmeyer as permanent CEO
      Nov 3Investing.comAVXL
      Anavex Deadline: AVXL Investors with Losses in Excess of $100K Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Oct 31MorningstarAVXL
      AVXL Stockholders Have Rights - If You Lost Money Investing in Anavex Life Sciences Corp. Contact Robbins LLP for Information About Recovering Your Losses
      Oct 28MorningstarAVXL
      AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Oct 26MorningstarAVXL
      What's Next for Anavex Life Sciences Corp. Shareholders After 6.35% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
      Oct 26MorningstarAVXL
      Anavex completes drug studies for Alzheimer’s treatment candidate
      Oct 20Investing.comAVXL
      AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Oct 20MorningstarAVXL
      Anavex: Downgrading To Sell On Blarcamesine MAA Withdrawal For AD, Pipeline Change (AVXL)

      Anavex Life Sciences Corp. is cut from Strong Buy to Sell after FDA/EMA setbacks. Click to read this latest AVXL stock update.

      Oct 16Seeking AlphaAVXL
      Anavex Receives FDA IND Clearance for Blarcamesine in Fragile X Syndrome, Enabling Phase 2a Trial
      Oct 16Yahoo FinanceAVXL
      Anavex Gets FDA Clearance to Study Blarcamesine in Fragile X Syndrome
      Oct 15Yahoo FinanceAVXL
      Anavex receives FDA clearance for Fragile X syndrome trial
      Oct 15Investing.comAVXL
      AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
      Oct 15MorningstarAVXL
      Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
      Oct 12MorningstarAVXL
      Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
      Oct 8MorningstarAVXL
      SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. Lawsuit - AVXL
      Oct 8MorningstarAVXL
      Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) to Contact the Firm to Learn About Their Legal Rights

      NewMediaWire Press Release.

      Oct 7The Globe and MailAVXL
      Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 30, 2026 - AVXL
      Oct 7MorningstarAVXL
      Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor Harm
      Oct 5MorningstarAVXL
      AVXL Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Filed Against Anavex Life Sciences Corp.
      Oct 2MorningstarAVXL
      AVXL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
      Sep 30MorningstarAVXL
      Anavex Life Sciences board election triggers change in control and full vesting of awards
      Sep 28Investing.comAVXL
      Anavex stockholders elect six directors at annual meeting
      Sep 24Investing.comAVXL
      Anavex Life Sciences Shareholders Elect All Six Board Nominees
      Sep 24Yahoo FinanceAVXL
      PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences

      -- Believes Anavex Needs New Leadership with Deep Industry Experience and Credible Strategic Plan to Turn the Company Around and Unlock Value for Shareholders –CENTENNIAL, Colo., Sept. 18, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. (“PVG”), a stockholder of 337,663 shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex” or the “Company”), announced its plan following its anticipated success in the Company’s upcoming proxy vote. PVG management is optimistic that its slate of highly

      Sep 18Yahoo FinanceAVXL
      Glass Lewis says Anavex shareholders should vote for PVG Asset nominees

      Glass Lewis urges Anavex shareholders to back PVG nominees Hogue and Kolbert, oppose Ma and van der Velden. Read more here.

      Sep 17Seeking AlphaAVXL
      Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing “Functionally Inert Stewardship” in Support of PVG Asset Management’s Call for Change

      -- Proxy advisor recommends voting “FOR” two of PVG’s director nominees and “AGAINST” two incumbent director nominees including the board’s current chair on the GOLD Universal Proxy Card – -- PVG encourages stockholders to vote to elect all six of its director nominees by voting the GOLD Universal Proxy Card to help the Company realize the full potential of its valuable assets -- CENTENNIAL, Colo., Sept. 17, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. (“PVG”), a stockholder of 337,663 sh

      Sep 17Yahoo FinanceAVXL
      PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance

      -- Yet ISS gives Anavex Board a free pass on years of failed governance and shareholder value destruction by supporting the current board’s nominees – -- It’s too little, too late after a few months of the incumbent board’s half-measures, so stockholders are encouraged to vote the GOLD Universal Proxy Card to elect PVG’s six nominees to help Anavex realize the full potential of its valuable assets while there’s still time -- CENTENNIAL, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PVG Asset Managem

      Sep 14Yahoo FinanceAVXL
      ISS backs Anavex board nominees in proxy fight
      Sep 14Investing.comAVXL
      PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign

      CENTENNIAL, Colo., Sept. 10, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. ("PVG"), a stockholder of Anavex Life Sciences Corp. (NASDAQ: AVXL) ("Anavex" or the "Company"), today announced that it will host an investor conference call to discuss its campaign for change in the Anavex Board of Directors at the upcoming 2026 Annual Meeting of Stockholders. During the call, PVG will discuss its views regarding the Company's recent performance, corporate governance, capital markets strategy, lea

      Sep 10Yahoo FinanceAVXL
      Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial
      Sep 10Investing.comAVXL
      PVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL)

      Why the Anavex Board should be replaced and a New CEO hiredCENTENNIAL, Colo., Sept. 09, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. ("PVG"), a stockholder of Anavex Life Sciences Corp. (Nasdaq: AVXL "Anavex" or the "Company"), believes the Anavex Board of Directors should be replaced and an experienced CEO should be hired. The “rookie” CEO held five positions across four organizations in seven years, none held longer than about 27 months.(1) On 27 February 2026, during her tenure as Aard

      Sep 9Yahoo FinanceAVXL
      Anavex gains as PVG calls for board reshuffle (AVXL:NASDAQ)
      Sep 4Seeking AlphaAVXL
      PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company

      CENTENNIAL, Colo., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. (“PVG”), a stockholder of Anavex Life Sciences Corp. (“Anavex” ...

      Sep 4Business InsiderAVXL
      PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company

      CENTENNIAL, Colo., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corp. (“PVG”), a stockholder of Anavex Life Sciences Corp. (“Anavex” or the “Company”), today sent an open letter to the stockholders of Anavex.In its letter, PVG details why it is calling for change at Anavex. PVG notes that the Company’s Board of Directors (the “Board”) has demonstrated a pattern of operational and corporate governance failures, a lack of accountability, and a failure to deliver meaningful shareholder v

      Sep 3Yahoo FinanceAVXL
      Anavex Life Sciences regains Nasdaq compliance
      Sep 2Investing.comAVXL
      Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports
      Sep 2Yahoo FinanceAVXL
      PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting

      CENTENNIAL, Colo., Sept. 01, 2026 (GLOBE NEWSWIRE) -- PVG Asset Management Corporation (“PVG”), together with the other participants named below, has filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GOLD Universal Proxy Card with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies from stockholders of Anavex Life Sciences Corp. (Nasdaq: AVXL) (the “Company”) for the Company’s 2026 annual meet

      Sep 1Yahoo FinanceAVXL
      Anavex Stock: After The EU Said No, The FDA Path Looks Long And Expensive (NASDAQ:AVXL)

      Anavex (AVXL) rated Sell: blarcamesine trial failures, EU regulatory missteps, and high dilution risk despite $118M cash. Read here for a detailed analysis.

      Aug 26Seeking AlphaAVXL
      Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028

      Anavex Life Sciences (NASDAQ:AVXL) is advancing Alzheimer’s Phase 3 planning with the FDA after submitting its clinical trial data to a newly opened Alzheimer’s IND, while reporting $118. 3 million in cash and an expected operating runway into mid to late fiscal 2028.

      Aug 25Yahoo FinanceAVXL
      Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

      Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

      Aug 25BarchartAVXL
      Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update

      Clinical Development Strategy for Alzheimer’s Disease Remains the Focus as Anavex Advances Regulatory Progress Across All Three Programs Anavex Submits...

      Aug 25BarchartAVXL
      Anavex Life Sciences Shares Rise After Q3 Swings to Profit

      Anavex Life Sciences (AVXL) shares rose over 13% on Tuesday after the company's fiscal Q3 swung to p

      Aug 25Yahoo FinanceTESTAVXL

      This is the newest page. Registered accounts read further back.